South Africa's health minister said on Wednesday the government may sell or swap its doses of the AstraZeneca Covid-19 vaccine, but it would wait for advice from scientists as it prepares to roll out an alternative U.S. shot next week. South Africa paused the rollout of the vaccine developed by AstraZeneca and Oxford University following data in a small clinical trial that showed it did not protect against mild to moderate illness from the 501Y.V2 variant of the coronavirus now dominant in the country.
from Engineering News | Home https://ift.tt/2Z1gpsP
